James Wright

Huge milestone announcement: Initial results from the #VAPOR2 Study have been published in the Journal of Urology, demonstrating encouraging ablative efficacy & favorable safety profile with the #Vanquish System. Long-term outcomes will be further evaluated in future analysis. 🔗tinyurl.com/VAPOR2Results Rx Only. FDA Cleared. See francismedical.com for safety info. @arvinkgeorge @tanejauro @JohnsHopkins, @NorthwellHealth

💧The first commercial #Vanquish® procedure has been performed by @AbhinavSidana at @UChicagoMed, bringing a new #MinimallyInvasive option to patients in the Chicago area. More: tinyurl.com/VanquishInChicag… Rx Only. FDA Cleared. See francismedical.com for safety info. #Urology

💦 Momentum builds! Naveen Kella, MD, of @theurologyplace, performed the first commercial procedures in San Antonio, TX, using the #Vanquish® Water Vapor Ablation System. ➡️ PR: tinyurl.com/VanquishExpansio… Rx Only. FDA Cleared. See francismedical.com for safety information. #Urology

🚀 As adoption continues to grow, we’re proud to announce the first commercial (non-clinical trial) procedure in the Midwest using the Vanquish® Water Vapor Ablation System. The procedure was performed by @aaron_milbank, MD, of @MN_Urology at High Pointe Surgery Center in Lake Elmo, Minnesota, marking the first use of the Vanquish System in routine clinical practice in the region. Developed by Francis Medical, the #Vanquish System is designed to ablate targeted prostate tissue using high-energy sterile water vapor delivered via a transurethral approach. Thank you to Dr. Milbank, Minnesota Urology, and High Pointe Surgery Center for their collaboration and leadership in bringing this #Innovation into routine clinical practice for select patients. Congratulations to all involved in reaching this important milestone. Read more: tinyurl.com/FirstInMidwest Rx Only. FDA Cleared. See francismedical.com for safety information. #FirstProcedure #Urology

Looking back at the European Association of Urology Congress (#EAU26), we’re grateful for the opportunity to connect with the urology community during an evening focused on advancing care. Thank you to everyone who joined us for the dinner and presentation, and to Dr. Arvin George for sharing insights from the #VAPOR2 Study on patient experience. This novel, multi-center trial is evaluating the #Vanquish® Water Vapor Ablation System, a transurethral thermal water vapor approach to ablate prostate tissue, with data now reported on the first 110 patients at 12-month follow-up. We appreciate the engagement and thoughtful discussion around emerging, evidence-based approaches to care. Explore the evidence: francismedical.com/evidence Rx Only. FDA Cleared. See francismedical.com for safety information. #ThankYou @Uroweb @arvinkgeorge

“We evaluate emerging technologies carefully to ensure they align with our clinical standards, safety, and patient-centered approach to deliver minimally invasive options supported by clinical evidence and responsible adoption.” — Dr. Rahul Mehan At Francis Medical, advancing innovation starts with evidence. The clinical foundation behind the Vanquish® System reflects a commitment to safety, thoughtful adoption, and delivering meaningful outcomes for patients. ➡️ Explore the #VAPOR2 Study evidence and learn more in the press release: francismedical.com/evidence Rx Only. FDA Cleared. See francismedical.com for safety information. #Vanquish @RahulMehan1 @EVUCENTER

Momentum continues to build for the Vanquish® Water Vapor Ablation System with expanded commercial use in the Southeastern United States. Recent procedures were successfully performed in Atlanta, Georgia, by Drs. Neal Patel and Jason Lomboy of Advanced Urology at Johns Creek Surgery Center and Marietta Surgery Center, respectively. Developed by Francis Medical, the #Vanquish System delivers high-energy sterile water vapor via a transurethral approach to ablate targeted prostate tissue. Thank you to Dr. Patel, Dr. Lomboy, Advanced Urology, and the teams at Johns Creek and Marietta Surgery Centers for their leadership in advancing #PatientCare. Learn more: tinyurl.com/VanquishPR Rx Only. FDA Cleared. See francismedical.com for safety information. #Urology #Innovation @itsdrpatel @AdvancedUroGA

We’re proud to announce the first commercial (non-clinical trial) procedures in Arizona using the #Vanquish® Water Vapor Ablation System. The procedures were performed by Rahul Mehan, MD, of East Valley Urology Center of Arizona at Verve Surgery Center, marking the first use of the Vanquish System in routine commercial practice in the state. This milestone reflects thoughtful adoption, physician training, and a shared commitment to advancing minimally invasive procedural innovation. Developed by Francis Medical, the Vanquish System is intended for the ablation of prostate tissue using high-energy sterile water vapor delivered via a transurethral approach. #ThankYou to Dr. Mehan (@RahulMehan1 ), Verve Surgery Center, and East Valley Urology Center (@EVUCENTER) of Arizona, whose support helped make this milestone possible. Congratulations to all involved in leading the way. Read more about this exciting news. 📄 Press Release: francismedical.com/news Rx Only. FDA Cleared. See francismedical.com for safety information. #FirstProcedure

What are the advantages of a procedure using the #Vanquish® Water Vapor Ablation System? #VAPOR2 Study results demonstrated: ☑️ Outpatient procedure (ASC or hospital) ☑️ Majority of patients experience almost no pain ☑️ Minimal impact on daily activities during recovery ☑️ Minimal urinary incontinence ☑️ Low rates of erectile dysfunction ☑️ Allows for future prostate procedures, if necessary Discover more about this new option for men: francismedical.com/vanquish-… Rx Only. FDA Cleared. See francismedical.com for safety information. #ProstateHealth #Urology #MinimallyInvasive #FocalTherapy

“This breakthrough technology holds the promise of minimizing the life-altering side effects commonly encountered with conventional, more aggressive prostate treatments.” — Dr. Christopher Dixon 💦 Water vapor technology is designed to ablate prostate tissue with the thermal energy stored in sterile water vapor. The #Vanquish® #WaterVaporAblation System delivers targeted applications of thermal energy using a transurethral procedure. See the science behind this approach: francismedical.com/science/ Rx Only. FDA Cleared. See francismedical.com for safety information. #MinimallyInvasive

“The patient satisfaction data further supports the exciting potential of the Vanquish technology,” said Dr. Arvin George (@arvinkgeorge), director of Prostate Cancer Programs at the Brady Urological Institute, Johns Hopkins University, and a VAPOR 2 co-principal investigator. “Most patients experienced no pain, quickly resumed daily activities, and indicated high rates of satisfaction with their procedure and decision at 12 months.” Echoing #VAPOR2 Study results: 93% of patients were extremely satisfied or satisfied at 12 months, with minimal to no pain reported. The #Vanquish® System is cleared for thermal ablation of targeted prostate tissue via transurethral approach. 🔗 More: francismedical.com Rx Only. FDA Cleared. See francismedical.com for safety information. #ProstateHealth #Urology #MedTech #Innovation @brady_urology

💦 We’re proud to celebrate the first Vanquish® procedure in routine commercial practice on the East Coast. Performed by Dr. Robert Given of Urology of Virginia at Chesapeake Regional Surgery Center, this milestone reflects continued momentum as physicians bring this innovative, minimally invasive option into everyday practice. Thank you to Dr. Given, Urology of Virginia, and Chesapeake Regional Surgery Center for advancing care and expanding access. Congratulations to all involved! Learn more in the full press release: 👉 francismedical.com/news Developed by Francis Medical, the #Vanquish System is designed to ablate prostate tissue using high-energy sterile water vapor delivered via a transurethral approach. Rx Only. FDA Cleared. See francismedical.com for safety information. #FirstProcedure #Innovation @UrologyofVA